Chronic lymphocytic leukemia (CLL) patients treated with a low number of CAR T cells targeting CD19 and containing the co-stimulatory signaling domain of CD137 exhibited a CR. Here, CD19 is linked to B-cell chronic lymphocytic leukemia.